Centrica confirms 2.0p interim dividend but this RNS leaves the key numbers elsewhere

What has Centrica announced?

Centrica has published its interim results for the six months ended 30 June 2026 and proposed an interim dividend of 2.0p per share.

However, there is an important limitation for investors reading this particular announcement. The RNS is effectively a publication notice rather than the full results statement. It directs readers to a separate interim report, but does not reproduce the company's revenue, profit, cash flow, net cash or operational performance figures.

That means the dividend and its payment timetable are the main pieces of financial information investors can assess from the supplied announcement alone.

Key item	Detail
Reporting period	Six months ended 30 June 2026
Proposed interim dividend	2.0p per share
Ex-dividend date	20 August 2026
Record date	21 August 2026
Payment date	22 September 2026
Revenue	Not disclosed in this RNS
Profit	Not disclosed in this RNS
Cash flow	Not disclosed in this RNS
Balance-sheet position	Not disclosed in this RNS
Comparative dividend	Not disclosed in this RNS

The 2.0p dividend is the clear headline

The proposed interim dividend is 2.0p for each ordinary share held. Centrica says it will pay the dividend on Tuesday, 22 September 2026 to shareholders on the register on Friday, 21 August 2026.

The shares are scheduled to trade ex-dividend on Thursday, 20 August 2026. The ex-dividend date is the point from which a buyer would generally no longer be entitled to receive this particular payment.

For context, an investor holding 1,000 qualifying shares would receive £20 before considering any personal tax position. That is simply the 2.0p payment multiplied by 1,000 shares.

Centrica also says it has sufficient distributable reserves to pay dividends to its ultimate shareholders. Distributable reserves are accumulated profits that are legally available for distribution. The company states that the parent entity has adequate realised profits within retained earnings to support the payment.

That is useful confirmation, but it is not the same as evidence about the wider group's current cash generation or financial performance. Those figures are not included in this short announcement.

What investors cannot judge from this filing

A half-year report would normally give shareholders enough information to examine trading momentum, profitability, cash conversion and the balance sheet. None of those core figures appears in the supplied RNS text.

In particular, the announcement does not disclose:

• revenue for the six-month period
• operating profit or adjusted profit
• earnings per share
• operating cash flow or free cash flow
• net cash or net debt
• performance by business division
• customer numbers or operational measures
• management guidance or an outlook statement
• comparisons with the previous half-year period

This matters because a dividend should ideally be considered alongside the earnings and cash flow supporting it. A 2.0p payment may look encouraging in isolation, but this notice does not provide enough information to assess its coverage, growth rate or sustainability.

It also does not disclose the previous interim dividend, so investors cannot calculate year-on-year dividend growth from this RNS alone.

Positives for Centrica shareholders

The most obvious positive is that Centrica has proposed a cash return to shareholders and supplied a clear timetable for payment.

The statement about distributable reserves is also reassuring at the parent-company level. It confirms that Centrica believes the legal reserves required to support the dividend are available.

There is no qualification attached to the proposed payment in the supplied text, and shareholders have firm dates for the ex-dividend, record and payment stages.

The main drawbacks and unanswered questions

The biggest negative is the lack of underlying financial detail in the announcement itself. Investors cannot use this RNS to judge whether the business improved or weakened during the first half of 2026.

There is also no outlook commentary. The filing does not say what management expects for the rest of the financial year, nor does it identify any trading risks, opportunities or changes in guidance.

Crucially, confirmation that distributable reserves are sufficient does not answer questions about future dividend affordability. For that, investors would need the full accounts, including earnings, cash flow, capital expenditure and balance-sheet information.

The announcement says the complete interim results are available separately and that an investor presentation for analysts and institutional investors is scheduled for 9.30am UK time on 23 July 2026. The contents of that report and presentation are not included in the supplied RNS text, so they cannot be assessed here.

What matters next for Centrica investors

The 2.0p interim dividend gives shareholders a tangible cash return and a defined payment date. On that narrow point, the announcement is clear.

But the investment significance of Centrica's half-year results cannot be determined from this publication notice alone. The key questions remain unanswered: how much the company earned, how much cash it generated, how its balance sheet changed and what management expects next.

Investors assessing the update should therefore distinguish between the confirmed dividend timetable and the missing operational and financial evidence. The payment is useful information, but it is only one part of the half-year picture.